Sign In
Buy GDRX
$3.04
+0.0900 (+3.05%)
At Close: Jul 13, 2026
GoodRx Announces Date for Second Quarter 2026 Earnings Release and Conference Call
04:05pm, Thursday, 09'th Jul 2026
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Company”), the leading platform for prescription savings in the U.S., today announced it will rele
GoodRx (GDRX) Upgraded to Buy: What Does It Mean for the Stock?
01:01pm, Wednesday, 08'th Jul 2026
GoodRx (GDRX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
GDRX or HQY: Which Is the Better Value Stock Right Now?
12:41pm, Wednesday, 08'th Jul 2026
Investors interested in Medical Services stocks are likely familiar with GoodRx Holdings, Inc. (GDRX) and HealthEquity (HQY). But which of these two stocks offers value investors a better bang for the
Is GoodRx (GDRX) Stock Undervalued Right Now?
10:41am, Wednesday, 08'th Jul 2026
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
GoodRx Launches GoodRx Companion, a New Subscription Designed to Lower Everyday Healthcare Costs
10:01am, Wednesday, 27'th May 2026
GoodRx (Nasdaq: GDRX), the leading platform for prescription savings in the U.S., today launched [url="]GoodRx Companion[/url], a new $14.99-per-month subscrip
GoodRx Launches GoodRx Companion, a New Subscription Designed to Lower Everyday Healthcare Costs
09:00am, Wednesday, 27'th May 2026
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx (Nasdaq: GDRX), the leading platform for prescription savings in the U.S., today launched GoodRx Companion, a new $14.99-per-month subscription that bring
3 Reasons Retirees Should Reconsider Enrolling in a Standalone Medicare Drug Plan in 2026
09:39am, Tuesday, 26'th May 2026
You turn 65, sign up for Medicare, and a wall of mail arrives pushing standalone Part D drug plans. The default move for decades has been to pick one and forget it. For 2026, that default deserves a f
GoodRx: TrumpRx Exposes Legacy Moat Breach And Zero-Sum Strategy (Downgrade)
11:46am, Wednesday, 20'th May 2026
GoodRx Holdings, Inc. faces ongoing revenue and margin pressure as its legacy business declines and Pharma Direct grows but with lower profitability. GDRX's Q1 results showed a 4% Y/Y revenue drop and
GoodRx Holdings, Inc. (GDRX) Q1 2026 Earnings Call Transcript
12:51am, Friday, 08'th May 2026
GoodRx Holdings, Inc. (GDRX) Q1 2026 Earnings Call Transcript
Big Pharma Runs Its Checkout Counter Through GoodRx
01:08pm, Thursday, 07'th May 2026
Out-of-pocket drug costs are rising for millions of Americans. Coverage gaps are widening.
Should You Add OPRX Stock to Your Portfolio Pre-Q1 Earnings?
11:30am, Thursday, 07'th May 2026
OptimizeRx nears Q1 earnings amid declining revenue forecasts, softer trends and a cautious outlook, raising questions on near-term upside.
GoodRx (GDRX) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
08:31pm, Wednesday, 06'th May 2026
The headline numbers for GoodRx (GDRX) give insight into how the company performed in the quarter ended March 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates
GoodRx Holdings, Inc. (GDRX) Q1 Earnings Match Estimates
07:35pm, Wednesday, 06'th May 2026
GoodRx Holdings, Inc. (GDRX) came out with quarterly earnings of $0.07 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.09 per share a year ago.
GoodRx Reports First Quarter 2026 Results
04:05pm, Wednesday, 06'th May 2026
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx Holdings, Inc. (Nasdaq: GDRX) ("we," "us," "our," “GoodRx,” or the “Company”), the leading platform for medication savings in the U.S., has releas
GoodRx Expands Offerings to Now Include Ozempic® Pill for Type 2 Diabetes Patients
08:10am, Friday, 01'st May 2026
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx (Nasdaq: GDRX), the leading platform for prescription savings in the U.S., today announced that it is providing access to self-pay pricing for Novo Nordis
